Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

0.8311
Delayed Data
As of Apr 18
 +0.1209 / +17.02%
Today’s Change
0.69
Today|||52-Week Range
6.74
-51.96%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 1.60, with a high estimate of 1.70 and a low estimate of 1.50. The median estimate represents a +92.52% increase from the last price of 0.83.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Hold stock in Conatus Pharmaceuticals Inc. This rating has held steady since March, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$7.9M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.92%
 
 
 
 
 
 
Growthannually 39.55%
 
 
 
 
 
 

Sales

Growthquarterly 6.34%
 
 
 
 
 
 
Growthannually -1.74%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.